Augmented Macular Pigment-containing Nutraceutical and Central Visual Function

Inclusion Criteria:

• Age ≥ 18 years
• Glaucoma diagnosis (H40. *) with abnormal visual field as measured by 30-2 HumphreyPerimetry (mean deviation < -2.00)
• Adequate IOP control (IOP > 7 mmHg and < 22 mmHg) by medical or surgical meansmeasured by Goldman Applanation Tonometry for at least 3 months
• Visual field progression - decrease (more negative) in MD by 1.00 dB or more whencompared to prior HVF)
• Refractive error ≤ 10 diopters and astigmatism ≤ 3 diopters

Exclusion Criteria:

• BCVA worse than 20/200
• Pt Is unable to tolerate MPOD, CS, dermal carotenoid measurement-taking procedures
• Loss of IOP control requires surgical intervention
• Patient already taking AREDS formula oral supplement
• Patient taking medication or dietary supplements that may interact with LM ingredients
• History of photosensitive epilepsy
• History of penetrating ocular trauma or vitrectomy
• History of ocular or orbital radiation therapy or is currently receiving chemotherapy
• Women who are nursing, pregnant, or are planning pregnancy
• Has a known adverse reaction (including sulfa allergy) and/or sensitivity to the studysupplement or its ingredients including: N-acetyl-cysteine, acetyl-L-carnitine,L-taurine, quercetin, Co-enzyme Q-10, lutein, meso zeaxanthin, zeaxanthin,astazanthin, lycopene, alpha-lipoic acid.
• Currently enrolled in an investigational drug study or has used an investigationaldrug within 30 days prior to recruitment.
• Is planning on having ocular surgery at any time throughout the study duration, or hadocular surgery < 3 months before enrollment
• Native lens opacity ≥ grade 3 on ARLNS standard photograph
• Blue light filter intraocular lens